S&P 500   4,664.86 (+1.53%)
DOW   35,196.48 (+0.85%)
QQQ   399.74 (+2.18%)
AAPL   160.69 (+2.47%)
MSFT   337.36 (+2.33%)
FB   339.29 (+1.85%)
GOOGL   2,913.24 (+2.45%)
AMZN   3,575.42 (+2.02%)
TSLA   1,126.54 (+4.12%)
NVDA   330.14 (+4.80%)
BABA   131.72 (-1.22%)
NIO   40.29 (+0.75%)
CGC   11.09 (-5.13%)
AMD   160.43 (+3.63%)
GE   98.92 (+1.10%)
MU   85.83 (+2.89%)
T   23.94 (-1.16%)
F   19.71 (-0.20%)
DIS   147.83 (-0.19%)
ACB   6.42 (-5.45%)
AMC   36.52 (-2.95%)
PFE   53.06 (-1.74%)
BA   197.40 (-0.91%)
S&P 500   4,664.86 (+1.53%)
DOW   35,196.48 (+0.85%)
QQQ   399.74 (+2.18%)
AAPL   160.69 (+2.47%)
MSFT   337.36 (+2.33%)
FB   339.29 (+1.85%)
GOOGL   2,913.24 (+2.45%)
AMZN   3,575.42 (+2.02%)
TSLA   1,126.54 (+4.12%)
NVDA   330.14 (+4.80%)
BABA   131.72 (-1.22%)
NIO   40.29 (+0.75%)
CGC   11.09 (-5.13%)
AMD   160.43 (+3.63%)
GE   98.92 (+1.10%)
MU   85.83 (+2.89%)
T   23.94 (-1.16%)
F   19.71 (-0.20%)
DIS   147.83 (-0.19%)
ACB   6.42 (-5.45%)
AMC   36.52 (-2.95%)
PFE   53.06 (-1.74%)
BA   197.40 (-0.91%)
S&P 500   4,664.86 (+1.53%)
DOW   35,196.48 (+0.85%)
QQQ   399.74 (+2.18%)
AAPL   160.69 (+2.47%)
MSFT   337.36 (+2.33%)
FB   339.29 (+1.85%)
GOOGL   2,913.24 (+2.45%)
AMZN   3,575.42 (+2.02%)
TSLA   1,126.54 (+4.12%)
NVDA   330.14 (+4.80%)
BABA   131.72 (-1.22%)
NIO   40.29 (+0.75%)
CGC   11.09 (-5.13%)
AMD   160.43 (+3.63%)
GE   98.92 (+1.10%)
MU   85.83 (+2.89%)
T   23.94 (-1.16%)
F   19.71 (-0.20%)
DIS   147.83 (-0.19%)
ACB   6.42 (-5.45%)
AMC   36.52 (-2.95%)
PFE   53.06 (-1.74%)
BA   197.40 (-0.91%)
S&P 500   4,664.86 (+1.53%)
DOW   35,196.48 (+0.85%)
QQQ   399.74 (+2.18%)
AAPL   160.69 (+2.47%)
MSFT   337.36 (+2.33%)
FB   339.29 (+1.85%)
GOOGL   2,913.24 (+2.45%)
AMZN   3,575.42 (+2.02%)
TSLA   1,126.54 (+4.12%)
NVDA   330.14 (+4.80%)
BABA   131.72 (-1.22%)
NIO   40.29 (+0.75%)
CGC   11.09 (-5.13%)
AMD   160.43 (+3.63%)
GE   98.92 (+1.10%)
MU   85.83 (+2.89%)
T   23.94 (-1.16%)
F   19.71 (-0.20%)
DIS   147.83 (-0.19%)
ACB   6.42 (-5.45%)
AMC   36.52 (-2.95%)
PFE   53.06 (-1.74%)
BA   197.40 (-0.91%)
CVE:VIR

Viridium Pacific Group Stock Forecast, Price & News

C$0.38
+0.02 (+5.56%)
(As of 06/7/2019)
Add
Compare
Today's Range
C$0.37
C$0.41
50-Day Range
C$0.38
C$0.38
52-Week Range
C$0.36
C$1.15
Volume
26,500 shs
Average Volume
92,632 shs
Market Capitalization
C$37.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive VIR News and Ratings via Email

Sign-up to receive the latest news and ratings for Viridium Pacific Group and its competitors with MarketBeat's FREE daily newsletter.


About Viridium Pacific Group

Viridium Pacific Group Ltd., through its subsidiaries, engages in the production, possession, and selling of medical cannabis in Canada. It is also involved in the contract manufacturing of cannabis oil capsules. The company provides its products for adult use, and wellness and therapeutic daily use. Viridium Pacific Group Ltd. is headquartered in Mission, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
C$1.09 million
Cash Flow
C$0.13 per share
Book Value
C$0.29 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
C$37.52 million
Optionable
Not Optionable

MarketRank

Overall MarketRank

1.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Viridium Pacific Group (CVE:VIR) Frequently Asked Questions

Who are Viridium Pacific Group's key executives?

Viridium Pacific Group's management team includes the following people:
  • Mr. Jay Garnett, Pres, CEO & Director (Age 50)
  • Mr. Jarrett Malnarick, Sr. VP, COO & Director (Age 46)
  • Ms. Sze Wan Wong C.A., CPA, CA, CPA, Corp. Sec. & Strategic Advisor (Age 45)
  • Ms. Kamini Hitkari, Chief Financial Officer
  • Mr. Bob Howard, Exec. Officer

What other stocks do shareholders of Viridium Pacific Group own?

What is Viridium Pacific Group's stock symbol?

Viridium Pacific Group trades on the Canadian Venture Exchange (CVE) under the ticker symbol "VIR."

How do I buy shares of Viridium Pacific Group?

Shares of VIR and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Viridium Pacific Group's stock price today?

One share of VIR stock can currently be purchased for approximately C$0.38.

How much money does Viridium Pacific Group make?

Viridium Pacific Group has a market capitalization of C$37.52 million and generates C$1.09 million in revenue each year.

What is Viridium Pacific Group's official website?

The official website for Viridium Pacific Group is www.viridiumpacific.com.

How can I contact Viridium Pacific Group?

The company can be reached via phone at 604-837-8688.


This page was last updated on 11/29/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.